Delivery Order SPE2DB22D3004-SPE2DB25FQ68V
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,707.42 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single transaction within AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,025.16 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value transaction typical of pharmaceutical supply orders under the agency's medical procurement operations. The product will be performed from...
- The Defense Logistics Agency (DLA) awarded a $4,450.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg, with an ultimate completion date of September 5, 2025. This non-set-aside delivery order, issued on September 4, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, continues to serve as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $43,473.13 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60 count) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract supporting federal pharmaceutical procurement needs. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen's...
- The Defense Logistics Agency awarded a $36,477.84 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Otezla 30 mg tablets (60-count units). The contract is a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,436.87 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) under a firm fixed price contract. The order, issued on August 20, 2025, with an ultimate completion date of August 21, 2025, represents a non-competitive set-aside delivery order for pharmaceutical products to support federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $35,436.55 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a single line item fulfilling pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $17,101.64 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count packages) on August 22, 2025, with an ultimate completion date of August 25, 2025. The contract utilizes firm fixed price pricing with no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work...
- The Defense Logistics Agency awarded a $2,500.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count) on August 4, 2025, with an ultimate completion date of August 5, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a relatively small-value transaction within AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order valued at $11,258.73 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count packages). This firm fixed price contract, awarded on August 19, 2025, with completion expected by August 20, 2025, carries no set-aside designation and was competitively awarded. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FQ68VDelivery Order
The Defense Logistics Agency awarded a $4,030.74 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitively awarded contract employs firm fixed pricing and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order represents a task order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The delivery order fulfills pharmaceutical requirements for the Defense Health Agency and other federal healthcare systems as part of the DLA's ongoing effort to ensure reliable access to specialty medications and critical medical commodities across the military healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 9/11/25 |